SCHEMBL13870805

SCHEMBL13870805

CCc1cc2cc(C)ccc2nc1-c1cc(C)cc(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 2/20 0.42
▸ PDE3A Q14432 2/20 0.42
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ PSMB5 P28074 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ RXFP1 Q9HBX9 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ MAPT P10636 4/20 0.39
▸ NCK1 P16333 1/20 0.39
▸ BACE1 P56817 1/20 0.39
▸ PKM P14618 1/20 0.38
▸ PDE2A O00408 1/20 0.37
▸ GRM1 Q13255 2/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870804 0.88 MEN1 (0.41) MEN1KMT2APSMB5CYP1A2KDM4E
SCHEMBL13870800 0.87 KMT2A (0.47) MEN1KMT2ACYP1A2KDM4EALDH1A1
SCHEMBL14500806 0.84 KDM4E (0.47) PDE3BPDE3AMEN1KMT2AKDM4E
SCHEMBL13870806 0.82 PDE3B (0.38) PDE3BPDE3AMEN1KMT2ACYP1A2
SCHEMBL4097200 0.81 PDE10A (0.50) PDE3BPDE3AMEN1KMT2APSMB5
SCHEMBL13597686 0.78 MEN1 (0.54) PDE3BPDE3AMEN1KMT2APSMB5
SCHEMBL14500822 0.75 GPBAR1 (0.49) KDM4EALDH1A1L3MBTL1RXFP1NPSR1
SCHEMBL14500810 0.75 MAOB (0.45) PDE3BPDE3AKDM4EALDH1A1L3MBTL1
SCHEMBL12000236 0.75 MAPT (0.58) MEN1KMT2ACYP1A2KDM4EALDH1A1
SCHEMBL13870817 0.74 PDGFRB (0.44) PDE3BPDE3AMEN1KMT2APSMB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 — — US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 — — US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 — — US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 PDE3B 3736/4885PDE3A 3858/4885MEN1 1373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback